ATE215827T1 - Immunologische aktivität der rhamnolipide - Google Patents

Immunologische aktivität der rhamnolipide

Info

Publication number
ATE215827T1
ATE215827T1 AT95927153T AT95927153T ATE215827T1 AT E215827 T1 ATE215827 T1 AT E215827T1 AT 95927153 T AT95927153 T AT 95927153T AT 95927153 T AT95927153 T AT 95927153T AT E215827 T1 ATE215827 T1 AT E215827T1
Authority
AT
Austria
Prior art keywords
rhamnolipids
immunological activity
mono
saturated
polyunsaturated hydrocarbyl
Prior art date
Application number
AT95927153T
Other languages
English (en)
Inventor
Goran Piljac
Visnja Piljac
Original Assignee
Goran Piljac
Visnja Piljac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goran Piljac, Visnja Piljac filed Critical Goran Piljac
Application granted granted Critical
Publication of ATE215827T1 publication Critical patent/ATE215827T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Birds (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • AIDS & HIV (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
AT95927153T 1994-07-20 1995-07-20 Immunologische aktivität der rhamnolipide ATE215827T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/277,975 US5466675A (en) 1992-02-04 1994-07-20 Immunological activity of rhamnolipids
PCT/US1995/008787 WO1996002233A1 (en) 1994-07-20 1995-07-20 Immunological activity of rhamnolipids

Publications (1)

Publication Number Publication Date
ATE215827T1 true ATE215827T1 (de) 2002-04-15

Family

ID=23063162

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95927153T ATE215827T1 (de) 1994-07-20 1995-07-20 Immunologische aktivität der rhamnolipide

Country Status (8)

Country Link
US (2) US5466675A (de)
EP (1) EP0771191B1 (de)
JP (2) JP4316672B2 (de)
AT (1) ATE215827T1 (de)
AU (1) AU3126695A (de)
CA (1) CA2195419C (de)
DE (1) DE69526353D1 (de)
WO (1) WO1996002233A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7262171B1 (en) * 1998-02-24 2007-08-28 Paradigm Biomedical, Inc. Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics
EP1056462B1 (de) * 1998-02-24 2007-07-25 Paradigm Biomedical Inc. Verwendundung von Rhamnolipiden als Kosmetika
EP1889623A3 (de) * 1998-02-24 2009-04-08 Paradigm Biomedical Inc. Verwendung von Rhamnolipiden für die Wundheilung, für die Behandlung von Verbrennungen, Arteriosklerose, Organtransplantationen, Depressionen und Schizophrenie sowie für Kosmetikartikel
ATE473749T1 (de) * 1999-08-05 2010-07-15 Paradigm Biomedical Inc Verwendung von rhamnolipiden zur wundheilung, behandlung und vorbeugung einer zahnfleischerkrankung und periodontaler regeneration
US6921390B2 (en) * 2001-07-23 2005-07-26 Boston Scientific Scimed, Inc. Long-term indwelling medical devices containing slow-releasing antimicrobial agents and having a surfactant surface
US7262178B2 (en) 2003-03-24 2007-08-28 Polytechnic University Treatment of sepsis and septic shock
US20050164955A1 (en) * 2003-11-06 2005-07-28 Gross Richard A. Antifungal properties of various forms of sophorolipids
WO2008013899A2 (en) * 2006-07-27 2008-01-31 Aurora Advance Beauty Labs Rhamnolipid-based formulations
US8592381B2 (en) * 2008-12-18 2013-11-26 Rhamnopharma Inc. Method for treating rhinitis and sinusitis by rhamnolipids
IT1393093B1 (it) 2009-02-18 2012-04-11 Bluegreen Biotech S R L Miscela glicolipidica da oscillatoria planktothrix con attivita' immunomodulante ed antiinfiammatoria
WO2012077120A2 (en) 2010-12-09 2012-06-14 Y&B Mother's Choice Ltd. Natural formulations
US10434058B2 (en) 2010-12-09 2019-10-08 Y&B Mother's Choice Ltd. Natural formulations
US9474283B2 (en) 2010-12-09 2016-10-25 Y&B Mother's Choice Ltd. Formulations comprising saponins and uses thereof
EP2723348B1 (de) * 2011-06-21 2019-08-14 Anton Leighton Verfahren zur behandlung von adipositas
US9861702B2 (en) 2012-10-22 2018-01-09 Wisconsin Alumni Research Foundation Lipid-conjugated rhamnose for immune system recruitment and oncotherapy
DE102012221519A1 (de) * 2012-11-26 2014-05-28 Evonik Industries Ag Verfahren zur Isolierung von Rhamnolipiden
IL229836A0 (en) 2013-12-08 2014-03-31 Y & B Mother S Choice Ltd Formulations to reduce or suppress irritation to eye tissue
WO2016179249A1 (en) * 2015-05-05 2016-11-10 Logos Technologies, Llc A semi-continuous process for the production of rhamnolipids at high yield and titer
ES2898721T3 (es) 2016-12-22 2022-03-08 Oreal Uso de ramnolípidos para el tratamiento cosmético de la piel reactiva
EP3338762A1 (de) 2016-12-22 2018-06-27 L'oreal Verwendung von rhamnolipid zur behandlung von hautrötung
BR112019012193B1 (pt) 2017-04-28 2021-12-28 L'oreal Composição de desodorante, métodos para desodorização de material queratinizado e para o tratamento de odor corporal e uso da composição de desodorante
KR102112570B1 (ko) * 2019-01-28 2020-05-19 한국해양과학기술원 신규 람노리피드 화합물 및 이의 용도
WO2024011094A1 (en) * 2022-07-08 2024-01-11 Woolsey Pharmaceuticals, Inc. Regimen for treating amyotrophic lateral sclerosis having onset 24 months prior to treatment
CA3261255A1 (en) * 2022-07-08 2024-01-11 Woolsey Pharmaceuticals, Inc. TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS THAT ONSET 24 MONTHS BEFORE TREATMENT
CN116585352A (zh) * 2023-04-21 2023-08-15 江南大学 一种鼠李糖脂/富勒烯复合物在结肠炎药物及改善肠道微生物群中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135099A3 (de) * 1983-08-09 1987-05-13 Petrotec Systems AG Verfahren zur Herstellung von Tensiden
DE3405664A1 (de) * 1984-02-17 1985-09-05 Wintershall Ag, 3100 Celle Verfahren zur biotechnischen herstellung von rhamnolipiden und rhamnolipide mit nur einem ss-hydroxidecancarbonsaeurerest im molekuel
JPS63182029A (ja) * 1987-01-22 1988-07-27 Agency Of Ind Science & Technol リポソ−ム
US4933281A (en) * 1987-03-17 1990-06-12 The University Of Iowa Research Foundation Method for producing rhamnose
JPS63253025A (ja) * 1987-04-09 1988-10-20 Yamanouchi Pharmaceut Co Ltd ホスホリパ−ゼａ↓２阻害剤
EP0288965A2 (de) * 1987-04-29 1988-11-02 Hoechst Aktiengesellschaft Peptide mit Phospholipase A2- hemmender Wirkung
JPH0273093A (ja) * 1988-09-09 1990-03-13 Haruo Ogura ３−デオキシ−ｄ−グリセロ−ｄ−ガラクト−２−ノヌロピラノソン酸誘導体
IT1235162B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisosfingolipidi
FR2645741B1 (fr) * 1989-03-20 1995-06-23 Dior Christian Parfums Procede pour fixer un produit sur la membrane d'un keratinocyte au moyen d'une liaison ligand-recepteur, procede de preparation d'un tel produit, produit obtenu, composition cosmetique ou pharmaceutique le contenant et son procede de preparation
BE1005704A4 (nl) * 1992-02-04 1993-12-21 Piljac Goran & Piljac Visnja Farmaceutisch preparaat op basis van rhamnolipide.
BE1005825A4 (nl) * 1992-05-22 1994-02-08 Piljac Goran Oppervlakteactieve samenstelling op basis van rhamnolopide.

Also Published As

Publication number Publication date
EP0771191A4 (de) 1998-10-07
WO1996002233A1 (en) 1996-02-01
US5514661A (en) 1996-05-07
DE69526353D1 (de) 2002-05-16
JP4316672B2 (ja) 2009-08-19
EP0771191B1 (de) 2002-04-10
JPH10502925A (ja) 1998-03-17
JP2007308514A (ja) 2007-11-29
CA2195419C (en) 2008-01-22
EP0771191A1 (de) 1997-05-07
AU3126695A (en) 1996-02-16
CA2195419A1 (en) 1996-02-01
US5466675A (en) 1995-11-14

Similar Documents

Publication Publication Date Title
ATE215827T1 (de) Immunologische aktivität der rhamnolipide
FR2430410A1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
ATE229524T1 (de) Distamycin a analoga als antitumor- oder antivirale wirkstoffe
ATE1814T1 (de) 9-hydroxyalkylpurine, verfahren zu ihrer herstellung und 9-hydroxyalkylpurine als aktive mittel enthaltende therapeutische zusammensetzung.
NO170280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater
DE3683823D1 (de) 2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel.
SE8702907D0 (sv) Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same
RU96117038A (ru) Композиция для обработки полости рта
NO810478L (no) Fremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazolderivater
DE3172298D1 (en) Pharmaceutical compositions
GB2210556B (en) The use of 15-keto-16-halo-prostaglandins in cathartic compositions
FR2418214A1 (fr) Compose de formule 1-(2',6',6'-trimethylcyclohexyl)-hexane-3-ol utilise notamment comme fixateur pour compositions de parfums
SE9601677D0 (sv) New use
ATE129633T1 (de) Dermatologische und kosmetische zusammensetzung.
FR2426679A1 (de)
RU99107566A (ru) Производные, обладающие противосудорожным действием, пригодные для лечения невропатической боли
FR2445329A1 (fr) Derives du 11-bromo-14-oxo-15-hydroxy-imino-e-homo-eburnane, leur preparation et leur utilisation comme medicament
FR2420344A1 (fr) Nouveaux oxime-ethers, leur preparation et leur application therapeutique.
BR9611472A (pt) Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
EP0253378A3 (de) 13Beta-Alkyl-derivate von S541-Antibiotika zur Bekämpfung von Parasiten an Nutztieren und Pflanzen
FR2392966A1 (fr) Nouveaux acides uree-bis(naphtalene-sulfoniques et naphtalene-carboxyliques), leurs sels pharmaceutiquement acceptables, et leur utilisation therapeutique
FR2418792A1 (fr) Derives de 3-azabicyclo(3.1.0)hexane, procede pour leur preparation, compositions biologiquement actives les contenant et procede herbicide les utilisant
ATE206431T1 (de) Antifungal fusacandine
FR2374319A1 (fr) Furanne- et thiophenecarbaldehydes substitues et furylalkylcetones substituees et thienylalkylcetones substituees, utiles notamment comme agents anti-rhinovirus, et leur procede de preparation
FR2696746B1 (fr) Dérivés de l'acide benzèneborinique, leur préparation et leur utilisation comme intermédiaires de synthèse.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties